Navidea Biopharmaceuticals

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 06/23/19 - 02:04 pm
Merck
Keytruda
Melinta Therapeutics
Amag Pharmaceuticals
Palatin
Acer Therapeutics
Sanofi
Regeneron
Alexion
Pfizer
Roche
Navidea Biopharmaceuticals
Ascendis Pharma
Scholar Rock
Adaptive Biotechnologies
BridgeBio
IPOs
G Medical Innovations
Karuna
Morphic Therapeutics
Navidea stock jumps 76% after agreeing to $80 million Cardinal Health deal
Marketwatch
Tue, 09/6/16 - 09:52 am
Navidea Biopharmaceuticals
Cardinal Health
Lymphoseek
M&A
Navidea Biopharma posts fourth-quarter loss of $2.5 million
Yahoo/AP
Thu, 03/24/16 - 09:44 am
Navidea Biopharmaceuticals
earnings
Macrophage Therapeutics to Present Data Supporting Potential for Breakthrough with Manocept™ in Immunotherapy
Yahoo/BusinessWire
Sat, 12/13/14 - 11:18 am
Macrophage Therapeutics
Manocept
Navidea Biopharmaceuticals
FDA approves expanded label for Lymphoseek
Seeking Alpha
Wed, 10/15/14 - 08:10 am
FDA
Lymphoseek
Navidea Biopharmaceuticals
2 Small Biotech Plays Moving Up On Positive News
Seeking Alpha
Wed, 06/11/14 - 05:33 pm
Regado Biosciences
Navidea Biopharmaceuticals
2nd Half Of 2014 Biotechnology Catalysts: Part 1
Seeking Alpha
Tue, 05/27/14 - 11:53 am
AcelRx
Anacor
BioDelivery Sciences
Eagle Pharmaceuticals
MannKind
Navidea Biopharmaceuticals
Orexigen
Omeros
EnteroMedics
Progenics
Trimel Pharmaceuticals
2 More Bold Speculative Biotech Plays
Seeking Alpha
Sun, 09/29/13 - 01:34 pm
Geron
Navidea Biopharmaceuticals
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
Seeking Alpha
Sat, 05/4/13 - 10:32 am
Vertex Pharmaceuticals
Pharmacyclics
Novartis
Celsion
Peregrine Pharmaceuticals
Prana
Navidea Biopharmaceuticals
Cardinal Health
ONYX Pharmaceuticals
Bayer
Sarepta
Hyperion Therapeutics
Amarin
Medivation
Astellas
JNJ
Trius
Sangamo BioSciences
Companies That Can Mend The Biotech Market: Stephen Brozak
Seeking Alpha
Sat, 04/13/13 - 11:36 am
Trius Therapeutics
NuPathe
Navidea Biopharmaceuticals
Cytori
Cempra
Cardinal Health
BioTime
Alexza Pharmaceuticals
Aastrom Biosciences
This Week in Biotech
Motley Fool
Sun, 03/17/13 - 11:40 am
Navidea Biopharmaceuticals
Sinovac Biotech
Aeterna Zentaris
Spectrum Pharmaceuticals
Navidea drops after FDA nod for drug used in cancer patients
Fierce Biotech
Thu, 03/14/13 - 11:39 am
Navidea Biopharmaceuticals
FDA
breast cancer
Lymphoseek
Tackling Cancer: Breast Cancer's Biggest Current & Upcoming Players
Motley Fool
Tue, 03/12/13 - 05:36 pm
breast cancer
aromatase inhibitors
AstraZeneca
Novartis
Femara
Arimidex
SERMs
Nolvadex
Roche
Herceptin
GSK
Tykerb
Xeloda
Perjeta
Kadcyla
Immunogen
Lymphoseek
Navidea Biopharmaceuticals
Nexavar
ONYX Pharmaceuticals
Best And Worst FDA Drug Approval Stocks of 2013
TheStreet.com
Tue, 03/12/13 - 11:45 am
Arena Pharmaceuticals
Sarepta
Ziopharm
Delcath
Aveo Pharmaceutical
United Therapeutics
AP Pharma
Titan Pharmaceuticals
Navidea Biopharmaceuticals
Biogen Idec
Raptor Pharmaceuticals
Roche Leads Pack for Upcoming FDA Approvals
Motley Fool
Wed, 01/9/13 - 12:20 pm
FDA
drug approvals
Roche
T-DM1
Aveo
Delcath
Navidea Biopharmaceuticals
Lymphoseek
tivozanib
chemostat
Navidea Biopharmaceuticals Announces PDUFA Goal Date for Lymphoseek® New Drug Application Resubmission
Tue, 11/13/12 - 10:21 pm
Navidea Biopharmaceuticals
Lymphoseek
Navidea Biopharmaceuticals Announces Third Quarter 2012 Financial Results
Thu, 11/8/12 - 10:48 pm
Navidea Biopharmaceuticals
earnings
Navidea Biopharmaceuticals Resubmits New Drug Application for Lymphoseek® to FDA
Wed, 10/31/12 - 10:56 pm
Navidea Biopharmaceuticals
Lymphoseek
FDA
Navidea Biopharmaceuticals Posts Lymphoseek® NDA Update to Company Website
Wed, 10/10/12 - 07:46 pm
Navidea Biopharmaceuticals
NDA
Lymphoseek
Lymphoseek: No Quick Approval Here
Motley Fool
Wed, 09/26/12 - 11:13 am
Lymphoseek
Navidea Biopharmaceuticals

Pages